◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

iShares iBonds Dec 2028 Term € Corp Crossover UCITS ETF ACC (I28X) ETF Overview

Name: iShares iBonds Dec 2028 Term € Corp Crossover UCITS ETF ACC (I28X) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · DATA UPDATED 2026-09-02

iShares iBonds Dec 2028 Term € Corp Crossover UCITS ETF ACC (I28X) is an exchange-traded fund managed by BlackRock Asset Management Ireland - ETF. It manages roughly €69 million in assets.

Interactive chart & fund stats →

I28X Fund Statistics

Assets under management	€69 million
Fund family	BlackRock Asset Management Ireland - ETF
Inception	2025-10-08

The live price chart, fund profile and news are in the interactive I28X viewer.

Other Companies in —

ELFF · Deka Euro Corporates 0-3 Liquid UCITS ETF — €70 million
YMAP · YieldMax Big Tech Option Income UCITS ETF — £69 million
YYYY · YieldMax Big Tech Option Income UCITS ETF — €69 million
28IX · ISHARES IBONDS DEC 2028 TERM CORP CROSSOVER UCITS ETF EUR (DIST) — €69 million
LAUU · Amundi Australia (S&P/ASX 200) UCITS ETF - D-EUR — $69 million
LYPU · Amundi Australia (S&P/ASX 200) UCITS ETF - D-EUR — €69 million
XEEE · Xtrackers Europe Equity Enhanced Active UCITS ETF 1C — €68 million
QANT · iShares Quantum Computing UCITS ETF USD (Acc) — £68 million

← HZO All “I” companies I37B →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.